By expenditures
| Name | Title | Type |
|---|---|---|
| Martin Lespada | Chief Financial Officer | Auditee |
| Terrell Boston-Smith | CHIEF FINANCIAL OFFICER | Auditee |
| Qasim Collidge | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 390264 | 2025 | 2026-03-04 | GELMAN ROSENBERG & FREEDMAN | $37.84M |
| 350509 | 2024 | 2025-03-31 | Cliftonlarsonallen LLP | $35.80M |
| 301525 | 2023 | 2024-04-01 | Cliftonlarsonallen LLP | $27.46M |
| 52060 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $19.30M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 390264 | 2025 | 2026-03-04 | 1176450 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176449 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176448 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176447 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176446 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176445 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176444 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176443 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176442 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176441 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176440 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176439 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176438 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176437 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176436 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176435 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176434 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176433 | 2025-002 | Material Weakness | Yes | AB |
| 390264 | 2025 | 2026-03-04 | 1176432 | 2025-004 | Material Weakness | Yes | L |
| 390264 | 2025 | 2026-03-04 | 1176431 | 2025-003 | Material Weakness | Yes | M |
| 390264 | 2025 | 2026-03-04 | 1176430 | 2025-002 | Material Weakness | Yes | AB |
| 301525 | 2023 | 2024-04-01 | 967235 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967234 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967233 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967232 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967231 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967230 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 967229 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390793 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390792 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390791 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390790 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390789 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390788 | 2023-001 | Material Weakness | Yes | I |
| 301525 | 2023 | 2024-04-01 | 390787 | 2023-001 | Material Weakness | Yes | I |
| 52060 | 2022 | 2023-03-30 | 637755 | 2022-001 | Significant Deficiency | Yes | I |
| 52060 | 2022 | 2023-03-30 | 61313 | 2022-001 | Significant Deficiency | Yes | I |